Preliminary Study of Dornase Alfa to Treat Chest Infections Post Lung Transplant.

Clinical trial NCT01952470 · COMPLETED

Trial details

NCT number: NCT01952470
Sponsor: The Alfred
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Transplant Infection Lower Respiratory Tract Infection

Start date: 2013-10-31
Primary completion: 2017-08-23
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.